Upload
kennispark
View
213
Download
2
Tags:
Embed Size (px)
Citation preview
Harm de Vries - Twente Technology Fund
University of TwenteFunding your company, opportunities, rules
26 January 2012
Harm de Vries - Twente Technology Fund
A techno log y sp in -o f f i s a new company founded
to exp lo i t a p i ece o f i n te l l ec tua l p roper ty
c rea ted i n an academic i n s t i tu t ion or company
Harm de Vries - Twente Technology Fund
Creating a company is not a new research project;
it is a business project that is able to turn a technology
or an invention into a shareholders’ return.
Harm de Vries - Twente Technology Fund
Spin-off Process
Decision Phase Separation Phase Post
Harm de Vries - Twente Technology Fund
Why Commercialise IP?
• Non-core business, thus more focus / less distraction
• Better development in entrepreneurial environment
• Better external financing solutions (share risk and rewards with other parties)
• Expand presence in the marketplace
• Allow quicker growth than in the mother company
• No more drain on mother company’s resources
Harm de Vries - Twente Technology Fund
Spin-off or License?
Spin-Off
License
• Upside potential • Control • Focus • Employment
• Financial risk • Active role • Wait for return
• Quick return Royalties • No further investments / involvement
• Sit back and wait
• Limited upside • Loss of control (shelving)?
• Finding a proper licensee
+ -
Harm de Vries - Twente Technology Fund
NewCo
Venture Capitalist
IP Transfer
Research Coll. Capital
Labour & know-how
Office space
Common Shares
Prefe
rred S
hares
Separation Phase Post Separation
Harm de Vries - Twente Technology Fund
• Transfer of IP (how?)
• Future Collaboration (R&D, launching customer)
• Transfer / use of personnel
• Investment in cash or in kind
Separation Phase
Harm de Vries - Twente Technology Fund
Financing
• Bank loan
• Grants
• Friends & family
• Venture Capital
Post Separation Phase
Harm de Vries - Twente Technology Fund
VC Criteria• Unique product(s) and/or technology platform
• Skilled and committed team (with entrepreneurial spirit)
• Solid IP and IP ownership
• Clear market and medical need
• Exit potential within 3-5 years
• High expected internal rate of return (IRR)
• Realistic valuation
Harm de Vries - Twente Technology Fund
Investment ProcessSourcing
Meetings
Negotiations & StructuringDue diligence
Syndication & due diligence
Term Sheet
Contract drafting
Closing
Harm de Vries - Twente Technology Fund
Term Sheet• Focuses parties
• Secures exclusive position
• Reduces future misunderstandings
• Sets a time line for negotiations and closing
• Addresses the main concerns of VC investors
1. Did I pay the right price?
2. How will the funds be used?
3. How and when can I exit?
4. How can I retain the key persons?
Harm de Vries - Twente Technology Fund
use of milestones
staged investments
anti-dilution protection
Did����������� ������������������ I����������� ������������������ pay����������� ������������������ the����������� ������������������ right����������� ������������������ price?
liquidation preference
syndication
Harm de Vries - Twente Technology Fund
shareholders consent
board representations
information rights
business planning
How����������� ������������������ will����������� ������������������ thefunds����������� ������������������ be����������� ������������������
used?
corporate governance
veto rights
Harm de Vries - Twente Technology Fund
drag along right
How����������� ������������������ and����������� ������������������ when
can����������� ������������������ I����������� ������������������ exit?
redemption rights
registration rights (IPO)tag along right
Harm de Vries - Twente Technology Fund
share ownership
employment contract
How����������� ������������������ can����������� ������������������ I����������� ������������������ retain����������� ������������������ the����������� ������������������ key����������� ������������������ persons?
lock - upoption plan
reversed vesting
Harm de Vries - Twente Technology Fund
IncorporationCommon %Shares Holding
Professor A 600,000 60%University 400,000 40%
Total 1,000,000 100%
Incorporation
Harm de Vries - Twente Technology Fund
Angel RoundPre financing Seed round Post financing
Common % Shares Total %Shares Holding Amount issued # Shares Holding
Professor A 600,000 60% 600,000 40%University 400,000 40% 400,000 27%Angel 0% €250,000 500,000 500,000 33%
Total 1,000,000 100% €250,000 500,000 1,500,000 100%
Valuation Pre-money €500,000 Price per share €0.50Investment round €250,000Post-money €750,000
Harm de Vries - Twente Technology Fund
Series A RoundPre financing Series A Post financing
Common % Shares Issuance Total %Shares Holding Amount issued ESOP # Shares Holding
Professor A 600,000 40% 600,000 27%University 400,000 27% 400,000 18%Angel 500,000 33% 500,000 23%VC 1 €2,000,000 600,000 600,000 27%ESOP 110,000 110,000 5%Total 1,500,000 100% €2,000,000 600,000 110,000 2,210,000 100%
Valuation Pre-money €5,000,000 Price per share €3.33Investment round €2,000,000Post-money €7,000,000
Harm de Vries - Twente Technology Fund
Series B RoundPre financing Series B Post financing
Common Pref Total % Shares Issuance Total %Shares Series A # shares Holding Amount issued ESOP # Shares Holding
Professor A 600,000 - 600,000 27% 600,000 17%University 400,000 - 400,000 18% 400,000 11%Angel 500,000 - 500,000 23% 500,000 14%VC 1 600,000 600,000 27% €3,500,000 442,000 1,042,000 29%VC 2 - - 0% €6,500,000 820,857 820,857 23%ESOP 110,000 - 110,000 5% 65,000 175,000 5%Total 1,610,000 600,000 2,210,000 100% €10,000,000 1,262,857 65,000 3,537,857 100%
Valuation Pre-money €17,500,000 Price per share €7.92Investment round €10,000,000Post-money €27,500,000
Harm de Vries - Twente Technology Fund
Series C RoundPre financing Series C Post financing
Common Pref Total % Shares Issuance Total %Shares Series A+B # shares Holding Amount issued ESOP # Shares Holding
Professor A 600,000 - 600,000 17% 600,000 9%University 400,000 - 400,000 11% 400,000 6%Angel 500,000 - 500,000 14% 500,000 7%VC 1 1,042,000 1,042,000 29% €5,000,000 321,623 1,363,623 20%VC 2 820,857 820,857 23% €5,000,000 321,623 1,142,481 16%VC 3 - - 0% €15,000,000 964,870 964,870 14%VC 4 - - 0% €15,000,000 964,870 964,870 14%ESOP 175,000 - 175,000 5% 875,000 1,050,000 15%Total 1,675,000 1,862,857 3,537,857 100% €40,000,000 2,572,987 875,000 6,985,844 100%
Valuation Pre-money €55,000,000 Price per share €15.55Investment round €40,000,000Post-money €95,000,000
Harm de Vries - Twente Technology Fund
IPOPre financing IPO Post IPO
Common Pref Pref Pref Total Conversion % Shares Total %Shares Series A Series B Series C # shares & Stock split Holding Amount issued # Shares Holding
Professor A 600,000 600,000 715,733 9% 715,733 6%University 400,000 400,000 477,155 6% 477,155 4%Angel 500,000 500,000 596,444 7% 596,444 5%VC 1 600,000 442,000 321,623 1,363,623 1,626,651 20% 1,626,651 14%VC 2 820,857 321,623 1,142,481 1,362,852 16% 1,362,852 12%VC 3 964,870 964,870 1,150,983 14% 1,150,983 10%VC 4 964,870 964,870 1,150,983 14% 1,150,983 10%Flotation - €50,000,000 3,333,333 3,333,333 29%ESOP 1,050,000 1,050,000 1,252,533 15% 1,252,533 11%Total 2,550,000 600,000 1,262,857 2,572,987 6,985,844 8,333,333 100% €50,000,000 3,333,333 11,666,667 100%
Valuation IPO Pricing €125,000,000 Price per share (before split) €17.89Investment round €50,000,000 Price per share (after split) €15.00Postmoney €175,000,000
Harm de Vries - Twente Technology Fund!
Titel:
Venture Capital Term Sheets “a guide to structuring and negotiating venture capital transactions”
Authors:
H.F. de Vries and M.J. van Loon
Publisher:
Reed Business Information
ISBN13:
9789059016323